High response rates with single-agent belantamab mafodotin in relapsed systemic AL amyloidosis

Saved in:

Bibliographic Details
Published in:	Blood cancer journal (New York) Vol. 12; no. 9; pp. 128 - 3
Main Authors:	Khwaja, Jahanzaib, Bomsztyk, Joshua, Mahmood, Shameem, Wisniowski, Brendan, Shah, Raakhee, Tailor, Anish, Yong, Kwee, Popat, Rakesh, Rabin, Neil, Kyriakou, Charalampia, Sive, Jonathan, Esposti, Simona Degli, Larkin, Daniel F. P., Worthington, Sarah, Hart, Alyse, Dowling, Emma, Correia, Nuno, Bygrave, Ceri, Rydzewski, Andrzej, Jamroziak, Krzysztof, Wechalekar, Ashutosh D.
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 05-09-2022 Springer Nature B.V Nature Publishing Group
Subjects:	631/67/1059/2325 692/699/1541/1990/804 Antibodies, Monoclonal, Humanized Biomedical and Life Sciences Biomedicine Bortezomib Cancer Research Correspondence Hematology Humans Immunoglobulin Light-chain Amyloidosis - drug therapy Multiple Myeloma Neoplasm Recurrence, Local Oncology
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Correspondence-1 content type line 23
ISSN:	2044-5385 2044-5385
DOI:	10.1038/s41408-022-00717-2